Home/Filings/4/0001485003-17-000067
4//SEC Filing

Eleven Biotherapeutics, Inc. 4

Accession 0001485003-17-000067

$CARMCIK 0001485003operating

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:44 PM ET

Size

5.5 KB

Accession

0001485003-17-000067

Insider Transaction Report

Form 4
Period: 2017-05-19
Celniker Abbie
DirectorPresident and CEO
Transactions
  • Award

    Stock Option

    2017-05-19+8,0728,072 total
    Exercise: $1.48Exp: 2027-05-18Common Stock (8,072 underlying)
Footnotes (1)
  • [F1]The option was granted on May 19, 2017 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested.

Issuer

Eleven Biotherapeutics, Inc.

CIK 0001485003

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001485003

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:44 PM ET
Size
5.5 KB